Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations
調査の概要
詳細な説明
Despite proven benefits, the proportion of people with COPD who receive Pulmonary Rehabilitation (PR) is very small. The current model of a center-based PR program fails to address the needs of many patients with COPD. The most common patient barrier to attendance is travel to center-based programs, particularly for frail patients with more severe COPD who need transportation assistance. Home-based, unsupervised PR has been proposed as an alternative model to hospital-based programs and has been found to be safe and effective.
In this pilot study researchers will investigate barriers, facilitators and adherence to a home-based pulmonary rehabilitation program after hospitalization. The results of this pilot study will inform the second part of this study as a randomized control study under a different grant (Study 2/R33). Both quantitative and qualitative methods will be used for the evaluation.
10 patients will be enrolled in this pilot study and allocated to a home-based PR in order to polish the intervention before the randomized portion of the study. This pilot is supported by a grant mechanism (R61) explicitly oriented to adjust the intervention and identify barriers for the next randomized portion of this study (Study 2) supported by a separate grant mechanism (R33).
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Minnesota
-
Rochester、Minnesota、アメリカ、55905
- Mayo Clinic in Rochester
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria
- COPD related hospitalization and eligible for PR
- Age 40+
- Confidence (score > 5 in a self-efficacy question (1-10 scale): how confident you feel to use this system on a daily basis)
Exclusion Criteria
- Inability to walk (orthopedic-neurologic problems or confined to bed)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:なし
- 介入モデル:単一グループの割り当て
- マスキング:なし(オープンラベル)
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的:Intervention- Home Pulmonary Rehabilitation
Participants will be offered a Home-based pulmonary rehabilitation program with health coaching.
|
遠隔システムを使用した健康指導を伴う在宅呼吸リハビリテーション (PR)。これにより、患者は自宅で PR を完了できます。
このプログラムには、上肢と下肢の運動、症状(疲労、息切れ、身体活動、全体的な健康状態)の自己申告が含まれます。
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Adherence to One Balance Practice Routine
時間枠:Baseline to 3 months
|
Percentage of participants to adhere to one balance practice routine per day for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Adherence to Two Balance Practice Routine
時間枠:Baseline to 3 months
|
Percentage of participants to adhere to two balance practices routine per day for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Adherence to Daily Flexible Practice Routine
時間枠:Baseline to 3 months
|
Percentage of participants to adhere to the daily flexible practice routine for 6 out of the 7 days for 12 weeks prescribed via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
|
Completion of the Daily Self-assessment
時間枠:Baseline to 3 months
|
Percentage of participants to complete the daily self-assessment for 6 out of the 7 days for 12 weeks via the interactive home-based pulmonary rehabilitation program
|
Baseline to 3 months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Chronic Respiratory Questionnaire (CRQ) Physical Symptoms Summary
時間枠:Baseline, 3 months
|
The CRQ is a 20-question inventory assessing the areas of health related quality of life in dyspnea (shortness of breath), fatigue, emotion, and feelings of mastery of chronic respiratory disease.
The Physical Summary score includes dyspnea (symptom #1 in COPD) and fatigue (symptom #2 in COPD) domains.
The questions in each domain are added together and then divided by the number of questions.
The possible range is 1-7, where 1 is the worst and 7 the best.
|
Baseline, 3 months
|
|
Change in Chronic Respiratory Questionnaire (CRQ) Emotional Symptoms Summary
時間枠:Baseline, 3 months
|
The CRQ Emotion Summary score includes the emotion (independent factor for admissions and poor quality of life) and mastery (self-management) domains of the CRQ.
The scores for each domain are calculated by simply added together the answers and then dividing by the number of questions, the range is 1-7 where 1 is the worst and 7 the best.
|
Baseline, 3 months
|
|
Daily Physical Activity
時間枠:3 months
|
Average number of steps per day recorded by ActiGraph activity monitor worn on the wrist for seven days at 3 months
|
3 months
|
|
Change in the Self-Management Ability Scale (SMAS) Total Score
時間枠:Baseline, 3 months
|
Measured using the total score from the self-reported SMAS 30 item questionnaire that measures ability and function.
A higher score indicates more ability and function in everyday life.
The SMAS30 has six areas, each with 5 questions.
The minimum score is one and the max is 5.
The mean is calculated for each section.
A higher score indicates better self management.
|
Baseline, 3 months
|
|
Change in Patient Health Questionnaire (PHQ-2)
時間枠:Baseline, 3 months
|
Measured using the self-reported PHQ-2 consisting of a 2 item questionnaire inquiring about the frequency of depressed mood over the past 2 weeks on a scale of 0 to 3, 0=Not at all, 1=several days, 2=more than half the days, 3=nearly everyday.
The minimum score is zero and the highest score is 6.
A score greater than 3 may indicate depression.
|
Baseline, 3 months
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Roberto P Benzo, MD、Mayo Clinic
出版物と役立つリンク
便利なリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 18-002453 (Pilot Study/R61)
- R61HL142933 (米国 NIH グラント/契約)
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。